Genautica

Diagnomics

Diagnomics is an early stage Next Generation Sequencing (NGS) and genomics company based in San Diego. It's seed capital investor is Genautica.

The company's founders are a team of eminently qualified scientists who were also the founders of PGI Korea - an NGS non-profit entity that sequenced the 1st woman, the 1st Korean and 2nd Asian. PGI also has an exclusive collaboration agreement with BGI Shenzhen, China - the leading genome center in the world.

Click a slide to view the full-size version of it
or
Download pdf file